Serina Therapeutics, Inc. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
Serina Therapeutics, Inc. (SER) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $173.00 thousand as of 2020-12-31, per its 10-K filed 2022-03-29.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2022-03-29
- 2020-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $173.00K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2020-12-31 | $173.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |